Skip to content

Treatment of one sided paralysis with Unani medicine Laooq-e-Anjeer Qawi and Roghan-e-Haft Barg

Clinical Validation of Unani Pharmacopoeial Formulations Laooq-e-Anjeer Qawi (Oral) and Roghan-e-Haft Barg (Local) in Falij-e-Nisfi (Hemiplegia) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077132
Enrollment
220
Registered
2024-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G819- Hemiplegia, unspecified

Interventions

Intervention1: Laooq-e-Anjeer Qawi and Roghan-e-Haft Barg: 5 gm (semisolid) orally to be taken with water twice daily and 10ml (oil) local application on the affected part twice daily respectively bot

Sponsors

Central Council for Research in Unani Medicine CCRUM New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Either gender, between 25-70 years of age. 2. Having the history of stroke at least 2 months and more. 3. Hemiplegia secondary to ischaemic stroke 4. Non Haemorrhagic Ischaemic stroke confirmed radiologically 5. Loss of function /weakness/paralysis of one side of the body. 6. No any significant pre- stroke disability

Exclusion criteria

Exclusion criteria: 1. Patients with altered sensorium or aphasia which is serious enough to impair Understanding of simple commands 2. Haemorrhagic stroke 3. Acute stroke cases 4. Pregnant and lactating women 5. Uncontrolled systemic illnesses including Hepatic, Renal and Cardiac diseases 6. Coexistence of major neurological and psychiatric diseases including epilepsy, seizures etc. 7. Conditions / circumstances where massage is contraindicated 8. Diabetes Mellitus. 9. Moderate to severe Hypertension 10. Deteriorating medical condition 11. Patients who fail to follow up 12. Patients who fail to give consent

Design outcomes

Primary

MeasureTime frame
The assessment of the efficacy of the study drugs will be carried out on the basis of reliable and valid scale -Stroke Rehabilitation Assessment of Movement (STREAM)Timepoint: At 0 week, 2nd week, 4th week, 6th week and at 8th week after completion of treatment

Secondary

MeasureTime frame
Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examinationTimepoint: At baseline and at the end of treatment i.e. 06 weeks

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

javed.ghazal@gmail.com9811810454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026